Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans
NCT ID: NCT02230098
Last Updated: 2015-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
50 participants
INTERVENTIONAL
2013-08-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will help to clarify whether remote ischemic preconditioning can be used to treat patients with ischemic heart disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Acute and Chronic Effects of Remote Ischemic Conditioning on Cardiovascular Function
NCT03984123
Risk of Pacing-induced Cardiomyopathy
NCT04269733
Prevention of Atrial Tachycardia After a Right Atriotomy
NCT00247351
The Effect of Enhanced External Counter Pulsation on Left Ventricular Systolic and Diastolic Function
NCT01112163
Cardiac Resynchronization Therapy in Congenital Heart Defects
NCT00450684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Ischemic Conditioning
By use of short-term obstruction of the blood supply to the arm
Remote Ischemic Conditioning
Before Remote Ischemic Conditioning
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Ischemic Conditioning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand the written patient information and to give informed consent.
Exclusion Criteria
* Strenuous exercise (running, bicycling, fitness), intake of beta-blockers or alcohol intake on the day before and on the day of investigation.
* Pregnant/nursing women.
* Fertile women not using contraceptives.
* Patients in dialysis treatment.
* Other concomitant disease or treatment that according to the investigator's assessment makes the patient unsuitable for study participation.
* Known type 2 diabetes
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leducq Foundation
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roni Ranghøj Nielsen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Aarhus University Hospital
Hans Erik Bøtker, Prof, MD, PhD, DMSc
Role: STUDY_DIRECTOR
Dept. of Cardiology, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, Region Central Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-124-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.